Literature DB >> 5221345

The interaction of human cholinesterases with anticholinesterases used in the therapy of myasthenia gravis.

F F Foldes, J C Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5221345     DOI： 10.1111/j.1749-6632.1966.tb45477.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  4 in total

1.  Stereoselectivity of cholinesterase inhibition by galanthamine and tolerance in humans.

Authors:  T Thomsen; U Bickel; J P Fischer; H Kewitz
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Acetylcholinesterase activity and menstrual remissions in myasthenia gravis.

Authors:  N Vijayan; V K Vijayan; P M Dreyfus
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-11       Impact factor: 10.154

3.  Plasma cholinesterase activity in patients during therapy with dexamethasone or prednisone.

Authors:  V Bradamante; E Kunec-Vajić; M Lisić; I Dobrić; I Beus
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  The inhibitory effect of esmolol on human plasmacholinesterase.

Authors:  E Barabas; E K Zsigmond; A F Kirkpatrick
Journal:  Can Anaesth Soc J       Date:  1986-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.